MSP Recovery Debt to Equity Ratio 2020-2024 | MSPR

Current and historical debt to equity ratio values for MSP Recovery (MSPR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. MSP Recovery debt/equity for the three months ending September 30, 2024 was 0.85.
MSP Recovery Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $1.94B $0.85B 2.29
2024-06-30 $1.88B $1.03B 1.81
2024-03-31 $1.79B $1.24B 1.44
2023-12-31 $1.74B $1.42B 1.23
2023-09-30 $1.64B $1.64B 1.00
2023-06-30 $1.61B $1.80B 0.89
2023-03-31 $1.54B $2.01B 0.76
2022-12-31 $1.23B $2.19B 0.56
2022-09-30 $1.18B $5.39B 0.22
2022-06-30 $1.15B $5.42B 0.21
2022-03-31 $0.14B $-0.02B -7.03
2021-12-31 $0.26B $-0.15B -1.69
2021-09-30 $0.25B $-0.02B -12.11
2021-06-30 $0.23B $0.01B 45.13
2021-03-31 $0.23B $0.01B 45.19
2020-12-31 $0.25B $-0.02B -11.79
2020-09-30 $0.23B $0.01B 45.29
2020-06-30 $0.00B $0.00B 5.00
2020-03-31 $0.00B $0.00B 0.00
2019-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.014B $0.008B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $6.068B 189.23
Tempus AI (TEM) United States $5.907B 0.00
Hims & Hers Health (HIMS) United States $5.552B 141.17
IRhythm Technologies (IRTC) United States $3.058B 0.00
Enovis (ENOV) United States $2.502B 16.96
Privia Health (PRVA) United States $2.461B 205.10
Azenta (AZTA) United States $2.362B 126.10
Omnicell (OMCL) United States $1.958B 64.06
10x Genomics (TXG) United States $1.886B 0.00
Clover Health Investments (CLOV) United States $1.824B 0.00
Phreesia (PHR) United States $1.551B 0.00
Schrodinger (SDGR) United States $1.405B 0.00
Butterfly Network (BFLY) United States $0.765B 0.00
Standard BioTools (LAB) United States $0.607B 0.00
Fulgent Genetics (FLGT) United States $0.560B 0.00
Talkspace (TALK) United States $0.493B 0.00
Definitive Healthcare (DH) United States $0.488B 84.40
Health Catalyst (HCAT) United States $0.419B 0.00
TruBridge (TBRG) United States $0.319B 93.04
Pulmonx (LUNG) United States $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
American Well (AMWL) United States $0.111B 0.00
EUDA Health Holdings (EUDA) Singapore $0.109B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
CareCloud (CCLD) United States $0.049B 0.00
Outset Medical (OM) United States $0.048B 0.00
Zepp Health (ZEPP) China $0.048B 0.00
Zhongchao (ZCMD) China $0.045B 0.00
111 (YI) China $0.042B 0.00
Movano (MOVE) United States $0.039B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00
SHL Telemedicine (SHLT) Israel $0.000B 0.00